![](/images/ico/ico_close.png)
![](/images/ico/ico3.png)
Period of time: 2016年2期
Publisher: Karger
Founded in: 1960
Total resources: 110
E-ISSN: 1421-9794|62|2
ISSN: 0009-3157
Subject: R96 Pharmacology
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Chemotherapy,volume 62,issue 2
Menu
![](/images/ico/ico5.png)
![](/images/ico/ico5.png)
![](/images/ico/ico5.png)
![](/images/ico/ico5.png)
![](/images/ico/ico5.png)
Bevacizumab in Ovarian Cancer: State of the Art and Unanswered Questions
Chemotherapy,volume 62,issue 2 , Vol. 62, Iss. 2, 2016-10 , pp.
![](/images/ico/ico5.png)
![](/images/ico/ico5.png)
![](/images/ico/ico5.png)
![](/images/ico/ico5.png)